AI-Powered Discovery Identifies Antibiotic 'Megacluster' to Combat Antibiotic-Resistant Superbugs

Researchers have used artificial intelligence to discover a new 'megacluster' of antibiotic compounds, representing a significant breakthrough in developing novel antibiotics to combat drug-resistant bacteria. The finding provides a fresh strategy for restocking the antibiotic arsenal as superbugs increasingly develop resistance to existing treatments.

Why it matters: AI-driven drug discovery is accelerating the identification of novel antibiotics, a critical capability as antibiotic resistance threatens modern medicine and healthcare systems worldwide.